7 followers
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
John Evans
Thermo Fisher Scientific
166 followers
Regeneron
94 followers
Agilent Technologies
63 followers
Alexion Pharmaceuticals
34 followers
Charles River Laboratories
11 followers
Cytiva
10 followers
Oxford Nanopore Technologies
5 followers
Taiho Oncology, Inc.
2 followers
Merck
216 followers
AbbVie
178 followers
Vir Biotechnology
3 followers
Explore companies